Interpret and apply results of the MPN-SAF TSS questionnaire to prognostication and treatment selection. Integrate approved agents into MF patient care in the 1L and 2L setting Identify disease progression, suboptimal response to treatment, and intolerance after 1L treatment Formulate and implement a shared-care model to connect MF care experts to community settings Monitor emerging agent clinical trial data for future integration to MF care
- Provider:Medical Education Resources
- Activity Link: https://mycme.com
- Start Date: 2024-09-10 05:00:00
- End Date: 2024-09-10 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: Source: CTI BioPharma - Amount: 5000.0 - Is Kind Support: False Source: Incyte Corporation - Amount: 5000.0 - Is Kind Support: False Source: Kayopharm - Amount: 5000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Jointly Provided
- Registration: Open to all
Warning: file_put_contents(/nas/content/live/sleepliteracy/wp-content/uploads/wpdiscuz/cache/comments/.htaccess): Failed to open stream: Permission denied in /nas/content/live/sleepliteracy/wp-content/plugins/wpdiscuz/utils/class.WpdiscuzCache.php on line 161